Incident Chronic Obstructive pulmoNary dIsease Cohort Study (ICONIC)

Recruiting N/A Interventional Study
Smokers Chronic Obstructive Pulmonary Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
35 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
300 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Chronic Obstructive Pulmonary Disease (COPD), , secondary to smoking, is a major public health issue with very high direct and indirect costs. The impact on the health system of undiagnosed patients, up to 70% of patients, is increasingly documented. However, systematic spirometry screening remains controversial among smokers in the absence of data to link the detection of new patients with improv…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Inclusion criteria of smokers with spirometry (pre-inclusion) * Age\> 35 years * Smoking \> 20 PA * Active smoking (cessation \< 1 month) * Signature of consent to participate in Phase I of the study Inclusion criteria for patients with incidental COPD * FEV1 / FVC \<70% of t…
Contacts

Laurent BOYER, MD

(0) 1 49 81 26 90

laurent.boyer@aphp.fr

CONTACT

Lila KACI

(0) 1 49 81 36 24

lila.kaci@aphp.fr

CONTACT